CD274 and thymic carcinoma: Although only a limited number of patients were included in each study due to the fact that TETs are a rare disease, PD-L1 expression was assessed in a total of 801 thymomas and 180 thymic carcinomas, with a wide range in positivity of 18%–92% and 36%–88%, respectively.